Prolensa (Bromfenac Sodium)

Prolensa Information:

Buy Prolensa

Prolensa (Bromfenac Sodium) is used to treat eye pain and inflammation following cataract surgery. Its active ingredient, Bromfenac Sodium, belongs to a group of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain enzymes that lead to the reduced production of prostaglandins, which are responsible for inflammation. This in turn reduces pain, redness, and other signs and symptoms of inflammation that may arise following cataract surgery.

Generic Prolensa from Canada

Canada Drugs Online is proud to serve you the brand Prolensa Ophthalmic Solution from Canada manufactured by Bausch & Lomb. The generic form of this medication is currently not available. Please call us toll-free at 1-877-900-3784 for details.

CanadaDrugsOnline.com also carries other Eye Care Medications such as Durezol and Cequa.

Prolensa Side Effects:

Common mild side effects of this medication include temporary irritation, burning, or stinging of the eye, temporary blurred vision, watery eyes, or headache. Please contact your doctor if any of these mild side effects do not resolve or worsen.

Possible serious side effects of this medication include edema, swelling, and fluid build-up in the center of the retina, blurry vision, blurry or wavy vision near or in the center of the field of vision, faded colors, severe body itching and rash, swelling of your face, lips, tongue, or throat, difficulty breathing, and extreme dizziness. If you experience these severe side effects, discontinue this medication and seek immediate medical attention. Also, inform your doctor about any other side effects not listed here.

Prolensa has been found to be clinically effective in reducing pain and inflammatory symptoms in the anterior chambers of the eyes following cataract surgery. When used as prescribed by a healthcare provider, it has been shown to be generally safe for use by most individuals. Bromfenac reaches its highest concentrations in the eyes approximately 150 to 180 minutes after administration and has a biological half-life of 1.4 hours.

Prolensa Directions:

This medication is typically applied as an eye drop, usually one drop into the affected eye once daily, starting the day before surgery and continuing for 14 days after surgery. Avoid contaminating the medication by ensuring that the dropper tip does not touch any surface, including the eye. Make sure to use the prescribed amount at the recommended frequency for the specified duration. Refer to the leaflet in the medication pack for more detailed usage instructions. Store this medication at room temperature, protect it from light and moisture, and keep it out of the reach of children.

Prolensa Precautions:

Before applying Prolensa, ensure you inform your doctor about any medical condition you previously or currently have, especially the following:
• Allergic reaction to Bromfenac Sodium, other ingredients of Prolensa, or any other medication;
• Bleeding disorders;
• Diabetes;
• Nasal polyps;
• Other eye disorders such as dry eye syndrome;
• Rheumatoid arthritis

Remove all contact lenses before applying this medication and wait at least 15 minutes after applying before putting your contact lenses back. It's important to avoid driving or using heavy machinery until you understand the impact of the medication on your body as this medication can cause blurry vision. This medication may be unsafe to use during the later stages of pregnancy. Therefore, consult your doctor before using this medication during pregnancy or while breastfeeding. Some medications may interact with Prolensa in the body, potentially increasing the risk of adverse effects. Some of these medications include:
• Anti-platelet medications such as Clopidogrel;
• Blood thinners such as warfarin, heparin;
• NSAID medications such as aspirin, ibuprofen.

Therefore, it is important to inform your doctor about all medications, including herbal supplements, that you are taking before using Prolensa to prevent potential drug interactions.